SENEB BIOSCIENCES INC has a total of 16 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are NEORPHYS, ALIHODZIC SULEJMAN and WU RONG TSUN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Sugars | |
#3 | Medical preparations | |
#4 | Fermentation | |
#5 | Peptides | |
#6 | Microorganisms | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Defrees Shawn | 15 |
#2 | Wang Zhi-Guang | 5 |
#3 | Johnson Karl Frank | 3 |
#4 | Wang Zhi Guang | 3 |
#5 | Defrees Shawn A | 1 |
#6 | Withers Stephen | 1 |
#7 | Johnson Karl F | 1 |
#8 | Vaughan Mark | 1 |
Publication | Filing date | Title |
---|---|---|
EP2817025A2 | Treatment of hypoglycemia | |
EP1765998A2 | Mutant endoglycoceramidases with enhanced synthetic activity | |
EP1603932A2 | Methods and compositions for the enzymatic synthesis of gangliosides | |
AU2002326805B2 | Novel synthetic ganglioside derivatives and compositions thereof |